BIOMAT Database Logo BIOMAT Database Logo

[Effects and side effects of levodopa in parkinsonism - results of a collaborative study. (6) Problems of long-term treatment of levodopa in parkinsoism]. 1976

K Uono

UI MeSH Term Description Entries
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008134 Long-Term Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Care, Long-Term,Long Term Care
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

K Uono
[Effects and side effects of levodopa in parkinsonism - results of a collaborative study. (3) Side effects of levodopa].
December 1976, Rinsho shinkeigaku = Clinical neurology,
K Uono
[Effects and side effects of levodopa in parkinsonism- results of a collaborative study].
December 1976, Rinsho shinkeigaku = Clinical neurology,
K Uono
[Effects and side effects of levodopa in parkinsonism - results of a collaborative study. (4) Dyskinesia caused by levodopa].
December 1976, Rinsho shinkeigaku = Clinical neurology,
K Uono
[Effects and side effects to levodopa in parkinsonism- results of a collaborative study. (5) Combined therapy with a peripheral decarboxylase inhibitor].
December 1976, Rinsho shinkeigaku = Clinical neurology,
K Uono
Long-term treatment of parkinsonism with levodopa.
December 1971, Postgraduate medicine,
K Uono
Long-term side-effects of levodopa.
February 1971, Lancet (London, England),
K Uono
Parkinsonism and long-term levodopa.
October 1980, Neurology,
K Uono
[Effects and side effects of levodopa in parkinsonism-results of a collaborative study. (1) Therapeutic responses in relation to the etiology and clinical types].
December 1976, Rinsho shinkeigaku = Clinical neurology,
K Uono
[Effects and side effects of levodopa in parkinsonism - results of a collaborative study. (2) The relationship between the age of the onset and therapeutic effects].
December 1976, Rinsho shinkeigaku = Clinical neurology,
K Uono
[Sustained levodopa efficacy in parkinsonism. Results of a four-year long-term follow-up study (author's transl)].
April 1977, Der Nervenarzt,
Copied contents to your clipboard!